385
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Corrigendum

This article refers to:
Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus – from the Spanish National Health System perspective

Mezquita-Raya P, Darbà J, Ascanio M, Ramírez de Arellano A. Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus – from the Spanish National Health System perspective. Expert Rev Pharmacoecon Outcomes Res. Available from: https://doi.org/10.1080/14737167.2017.1345628

When the above article was first published online, the below paragraph in section “2.2.1. Clinical data” was included in error. This paragraph has now been removed.

“To obtain the corresponding IDeg basal dose for T1DM B/B patients, the calculation was as follows: (1) the IGlar basal dose for T1DM B/B patients was 33.10 units/day; (2) the IDeg/IGlar basal dose ratio was 0.87; (3) the IDeg basal dose for T1DM B/B patients was 33.10 × 0.87 = 28.80 units/day. In patients with T2DM treated with B/B and BOT insulin, the estimation of IGlar OD was based on a randomized, 52-week, treat to-target trial comparing insulin detemir (IDet) with insulin IGlar by Rosenstock et al. [25]. After 52 weeks, the OD dose of IDet (n = 102) was 0.52 units/kg. Therefore, dose IDet (one injection) was 51.70 units/day. The mean dosage to achieve glucose goal was the same with both insulins: IDet and IGlar for which similar calculations applied to IGlar as for IDet [26]. Based on that, the corresponding doses for IGlar OD in T2DM patients treated with B/B and BOT insulin were 66.60 and 51.70 units/day, respectively (Table 1).”

The authors apologise for this error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.